CytoSorbents' CEO on flu epidemic

The Center for Disease Control estimates that the most prominent strain could leave as many as fifty thousand Americans dead by the end of this year's flu season. Here to discuss this year's flu season and what hospitals can do to address this epidemic is Phil Chan CEO of CytoSorbents.